Search

FDA Reports of Secondary Malignancies Following Chimeric Antigen Receptor (CAR) T Cell Therapies and Relative Risk: an EBMT-EHA-GoCART Coalition Statement

We need to bring your attention to the recent warning disseminated by the Food and Drug Administration (FDA) regarding T-cell lymphomas in patients undergoing Chimeric Antigen Receptor T-cell (CAR-T) therapy (1).

Read more

Meeting Program

EHA-SfPM Precision Medicine



Read more

Meeting Program

EHA-ISHBT Hematology Tutorial
Please note: all times are in India Standard Time (IST)

Read more

Good Governance Committee

Current committee members
Wim Fibbe, Netherlands (Chair)
Laurent Degos, France
Jean-Luc Harousseau, France
Cristina Mecucci, Italy
Helen Papadaki, Greece
Irene Roberts, United Kingdom
Pieter Sonneveld, Netherlands
AimThe Good Governance Committee (GGC) is responsible for guarding EHA’s image, position and performance as a non-profit membership organization for the public…

Read more